Epidemiological data on 448 cases of human cutaneous anthrax from the Gambia showed that this particular strain of anthrax bacillus causes widespread morbidity and some mortality with, at the same time, subclinical infection. Analysis also showed that anthrax is not an occupationally related disease in the Gambia.
hepatitis B virus. Other viruses, such as hepatitis A virus, Epstein-Barr virus, or cytomegalovirus, might have been responsible for the disease in HBsAg-negative patients in this (probably) virus-induced group.
Oxyphenisatin, methyldopa, and isoniazid may induce clinical and histopathological changes resembling CAH. 9-11 Our findings add a few more drugs to the list of possible trigger agents. Sulphonamides, phenylbutazone, and nitrofurantoin have been associated with acute liver damage,12-'4 and long-standing exposure to high doses might also be associated with the development of chronic liver disease. Hydrallazine has been associated with clinical and laboratory signs of systemic lupus erythematosus" and might be a trigger factor for CAH as well.
Almost 40%V of our patients already had morphological signs of CAH at the onset of clinical illness, and no trigger factor was shown. Cases of CAH within this group might have been virusor drug-induced, and studies on cellular immunity to HBsAgI6 might have shown more cases of probably viral origin.
Some reports have pointed out differences in prevalence of autoantibodies between HBsAg-positive and HBsAgnegative cases of CAH.'17 18 Our results only partly confirm these findings. No HBsAg-positive patient had high titres of autoantibodies, which agrees with previous observations. But HBsAg-negative patients with initial histological signs of viral hepatitis also lacked high titres of autoantibodies. The high prevalence of high-titre autoantibodies in the drug-induced and cryptogenic groups could be at least partly explained by the predominance of women in these groups, as has earlier been claimed by Reed et al.' 9 An increased frequency of HL-A 1 and HL-A 8 was found in the cryptogenic group. Mackay et al2 reported a high prevalence of HL-A antigens 1 and 8 among 37 patients with CAH who had not been separated according to possible trigger factors. Possibly patients with these HL-A types are more prone to develop CAH without an external precipitating factor. On the other hand, possibly these patients develop CAH because of impaired suppressor T-cell function, which might be linked to HL-A types 1 and 8.8 Thus it is not excluded that some trigger factor could be involved also in cryptogenic CAH. Evidence has been presented that subclinical hepatitis B infection could be such a factor even in patients without demonstrable serum HBsAg." But other trigger factors-so far undefined-could, of course, be involved in these genetically predisposed patients.
The possibility of human-to-human spread, affecting all age groups and both sexes, by means of a communal toilet article was also shown. The fact that the strain is a good toxin producer but contains a weak antigen may have accounted for the 
Discussion
Anthrax is a disease primarily of animals and only secondarily of man, in whom infectivity is thought to be low.2 The incidence, probably underestimated, in the Foni regions of the Gambia was 1 4%, with at least 45% of the villages of this region being affected over the past four years. Unlike most other diseases in the Gambia3 anthrax occurs almost entirely in the dry season. The anthrax bacillus germinates at 20-440C in a humidity of over 80%.0 These conditions are found in the wet season in the Gambia. The number of anthrax spores in the ground possibly falls at this time because germination occurs and the anthrax bacillus is destroyed by soil bacteria. There may be other factors in the dry season, such as winds distributing the spores and close cropping of the grass by animals. In some villages there were several cases in each year, in others many cases in one year were followed by few the next, and in some only one or two patients came for treatment in the four years. There is little movement of cattle, sheep, or goats between villages, but it is quite possible that vultures spread the disease. The people do not eat a dying animal, which may account for the few cases of gastrointestinal anthrax. This contrasts with anthrax in Kenya,5 but is similar to that in other parts of the world, where cutaneous anthrax is the most common form.6 The distribution of the cases in the Gambia by age, sex, and site of lesion was not similar to the pattern in Iran., Our results suggest that in the Gambia the disease is not related to occupation.
Though arthropods can transmit the disease, at least experimentally,' arthropod transmission was unlikely since most arthropods are much more common in the wet season, and the few which are active throughout the year, such as Stomoxys spp, tend to bite the lower leg, so the site distribution would have been different.
It is said that human-to-human transmission occurs only rarely,8 but it seems to be common in the Gambia for antibodies were found in people living in close contact with patients and B anthracis was isolated from communal loofahs. The mode of transmission may be similar to that which occurred as a result of infected shaving brushes in Great Britain and Russia8 and of the use of "Sepidab" in Iran.' The difference in the Gambia lies in the fact that these loofahs are shared within a family and so may facilitate human-to-human spread.
Antibody levels have not often been studied in large outbreaks of anthrax. Our results show a wide variation of response, with persistence for up to a year in some cases, even after treatment, and rapid disappearance in others. Antibodies were discovered in some people who had no history or evidence of anthrax. This pattern has been reported previously: 11 out of 72 otherwise healthy workers in a goat hair mill were found to have antibodies. 9 Recovery from anthrax is said to be followed by prolonged immunity and recurrences are said to be extremely rare,8 but we have not confirmed this in the Gambia. Serological examination showed that though antibodies may persist for 12 months (possibly as a result of repeated subinfective doses or subclinical attacks) there was at least one authenticated recurrence within 12 months of primary infection, which corresponded with the laboratory findings that this strain contains a weak antigen.
Unlike the mortality in Iran,' in the Gambia mortality was not related to any particular site, to the multiplicity of lesions, or to the extent of local inflammatory response. We did not confirm either that mortality and morbidity were related to the nutritional state of the people; on the contrary, their nutritional state was at its best at the time of maximum attack.
How can this disease be eradicated? It is not limited to the Gambia, being present in the adjoining area of Senegal. It is firmly established in animals, particularly sheep and goats, and it would be impossible to immunize these effectively. Humans could be immunized,'0 but three or four injections are needed to give even temporary immunity. An international organization would have to carry out an immunization programme and organize the necessary annual booster doses. Nevertheless, even temporary immunity may break the cycle by allowing a natural reduction of spore counts in the soil. Public health measures to ensure the correct disposal of animal carcases and the control of vultures may also help. An attempt could be made to change the habit of using the palm-fibre loofah, to limit its use to one per person, and to advise disposal of the loofah before it became contaminated with anthrax spores.
There is no evidence to suggest that the disease is declining in severity or prevalence, and from what is known of the antigenicity of this organism it is most unlikely that natural or "herd immunity" will protect the population even when they are repeatedly exposed to the disease. The converse may be true unless active steps are taken to check or eradicate the disease before it becomes endemic and spreads to other villages and areas of the country.
